Dr. Moon J. Noh has been with Kolon TissueGene for over 16 years. Prior to his role here, Dr. Noh was the Director of the Biotechnology Lab at Kolon Central Research Park. Dr. Noh holds a Ph.D. and M.S. from the Korea Advanced Institute of Science and Technology in Molecular Biology.

Soon-Wook Kweon joined Kolon TissueGene, Inc. in May, 2017 as the Chief Financial Officer. Before he joined Kolon TissueGene, he served as the Vice President of the Management & Finance Division in Kolon Corporation. He received his Bachelor of Arts in Economics at Korea University in Korea.

Jung In Kim joined Kolon TissueGene, Inc. in December, 2021 as the Chief Financial Officer and the Korea Branch leader. Before she joined Kolon TissueGene, she served as a director of the Management and Finance division in Kolon Corporation. She received his Bachelor of Arts in Mathematics at Kookmin University in Korea and acquired her CPA license from Korea Institute of Certified Public Accountant.

Sun Jin Kim joined Kolon TissueGene, Inc. in June 2021 as Chief Medical Officer. Also he serves as the Chairman and Founder of Platbio Inc in Korea.  He received his Ph.D. degree in the Medical Science at Seoul National University in Korea.

Diana M. Halim joined Kolon TissueGene, Inc. in January 2020 as Senior Director of Regulatory Affairs and shortly thereafter became Vice President of Clinical and Regulatory Affairs. She previously served as the Director of Regulatory Affairs at RRD International, LLC, Sucampo Pharmaceuticals, Inc., and AnGes, Inc. She received her B.A. degree in English/Biology from George Washington University, Washington, DC and her M.S. degree in Biotechnology from Johns Hopkins University, Baltimore, MD.